C. Gennari

S. Gonnelli, C. Cepollaro, C. Gennari, 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Treatment of post‐menopausal osteoporosis with recombinant human growth hormone and salmon calcitonin: a placebo controlled study

S. Gonnelli, A. Montagnani, C. Cepollaro, 1997, Clinical endocrinology.

Management of Osteoporosis and Paget’s Disease

R. Nuti, C. Gennari, G. Martini, 1994 .

Evidence forefficacy ofdrugs affecting bonemetabolism in preventing hipfracture

C. Gennari, E. Allander, L. Miravet, 1992 .

Calcitonin in the treatment of osteoporosis

C. Gennari, A. Camporeale, 2010, Osteoporosis International.

Calcitonin, Bone-Active Isoflavones and Vitamin D Metabolites

C. Gennari, 1999, Osteoporosis International.

Metabolic and clinical effects of ipriflavone in established post-menopausal osteoporosis.

C. Cepollaro, C. Gennari, S. Bigazzi, 1989, Drugs under experimental and clinical research.

Calcium and vitamin D nutrition and bone disease of the elderly

C. Gennari, 2001, Public Health Nutrition.

Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis.

Harry K. Genant, Claus Christiansen, C. Christiansen, 1993, The American journal of medicine.

R. Nuti, C. Gennari, G. Martini, 1995, Calcified Tissue International.

Intranasal Salcatonin (Salmon Calcitonin) A Review of its Pharmacological Properties and Role in the Management of Postmenopausal Osteoporosis

H. Rico, H. Nakamuta, C. Gennari, 1996 .

Hip fracture in Italy: epidemiology and preventive efficacy of bone-active drugs.

M. Passeri, C. Gennari, G. Pioli, 1993, Bone.

Bone alkaline phosphatase measured with a new immunoradiometric assay in patients with metabolic bone diseases

S. Gonnelli, A. Montagnani, C. Cepollaro, 1996, European journal of clinical investigation.

Prevention of Corticosteroid-Induced Osteoporosis with Alendronate in Sarcoid Patients

P. Rottoli, S. Gonnelli, C. Cepollaro, 1997, Calcified Tissue International.

Basic Aspects of Calcitonin in Skeletal Health

C. Gennari, 2003 .

Analgesic effect of calcitonin in osteoporosis.

C. Gennari, 2002, Bone.

An effective regimen of intranasal salmon calcitonin in early postmenopausal bone loss

R. Civitelli, S. Gonnelli, C. Gennari, 1992, Calcified Tissue International.

Effect of rectal salmon calcitonin treatment on bone mass and bone turnover in patients with established postmenopausal osteoporosis: A 1-year crossover study

S. Gonnelli, C. Gennari, R. Palmieri, 1993 .

Effects of salmon calcitonin in postmenopausal osteoporosis: A controlled double-blind clinical study

M. Passeri, G. Francini, S. Gonnelli, 2007, Calcified Tissue International.

Effect of salmon calcitonin nasal spray on bone mass in patients with high turnover osteoporosis

C. Gennari, D. Agnusdei, A. Camporeale, 2005, Osteoporosis International.

Salmon calcitonin (Miacalcic) nasal spray in prevention and treatment of osteoporosis

C. Gennari, 1989, Clinical Rheumatology.

Treatment of bone metastases with dichloromethylene bisphosphonate.

G. Francini, R. Petrioli, S. Gonnelli, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Serum Osteocalcin Concentration in Patients with Prostatic Cancer

G. Francini, C. Gennari, S. Bigazzi, 1988, American journal of clinical oncology.

Helicobacter pylori infection and infertility

P. Piomboni, C. Gennari, L. Gennari, 2002, European journal of gastroenterology & hepatology.

Aerobic exercise training fails to reduce blood pressure in nondipper-type hypertension.

S. Mondillo, E. Agricola, G. Ferro, 2000, American journal of hypertension.

Improved cardiac performance with human calcitonin gene related peptide in patients with congestive heart failure.

C. Gennari, R. Nami, D. Agnusdei, 1990, Cardiovascular research.

PTH in the pathogenesis and treatment of glucocorticoid-induced osteoporosis.

S. Gonnelli, C. Gennari, L. Gennari, 2002, Frontiers of hormone research.

Bone endothelial cells as estrogen targets

M. Brandi, C. Crescioli, C. Gennari, 1993, Calcified Tissue International.

Osteoblastic metastases from carcinoid tumor.

C. Gennari, E. Battisti, N. Giordano, 1994, Clinical and experimental rheumatology.

Estrogen preserves a normal intestinal responsiveness to 1,25-dihydroxyvitamin D3 in oophorectomized women.

R. Civitelli, C. Gennari, D. Agnusdei, 1990, The Journal of clinical endocrinology and metabolism.

Salmon calcitonin and cGMP production by human kidney: Studies in vivo and in vitro

M. Brandi, G. Francini, C. Rotella, 1983, Calcified Tissue International.

Influence of specific anti-salmon calcitonin antibodies on biological effectiveness of nasal salmon calcitonin in Paget's disease of bone.

J. Reginster, P. Franchimont, C. Gennari, 1990, Scandinavian journal of rheumatology.

Early effects of synthetic bovine parathyroid hormone and synthetic salmon calcitonin on urinary excretion of cyclic AMP, phosphate and calcium in man

R. Nuti, C. Gennari, A. Vattimo, 1976, Calcified Tissue Research.

Comparison between the results of radiocalcium studies and histological findings in a case of primary hyperparathyroidism (osteitis fibrosa cystica generalisata of von Recklinghausen) before and after removal of parathyroid adenoma.

C. Gennari, L. Cesari, A. Caniggia, 1966, The Journal of clinical endocrinology and metabolism.

Intestinal absorption of radio phosphate in osteomalacia before and after vitamin D treatment

C. Gennari, V. Palazzuoli, A. Caniggia, 2005, Calcified Tissue Research.

Cardiovascular effects of calcitonin gene-related peptides I and II in man.

A. Franco‐Cereceda, C. Gennari, J. Pernow, 1987, Circulation research.

Is there an effective treatment for glucocorticoid-induced osteoporosis?

L. Avioli, R. Civitelli, D. Villareal, 1991, Calcified Tissue International.

Glucocorticoid induced osteoporosis

C. Gennari, 1986, Clinical endocrinology.

Effects of one-year treatment with estrogens on bone mass, intestinal calcium absorption, and 25-hydroxyvitamin D-1α-hydroxylase reserve in postmenopausal osteoporosis

L. Avioli, R. Civitelli, C. Gennari, 1988, Calcified Tissue International.

Mild brachydactyly type A1 maps to chromosome 2q35-q36 and is caused by a novel IHH mutation in a three generation family

A. Renieri, F. Mari, R. Nuti, 2003, Journal of medical genetics.

Cardiovascular action of calcitonin gene-related peptide in humans

C. Gennari, J. Fischer, 1985, Calcified Tissue International.

Quantitative Ultrasound at the Phalanges in Healthy Italian Men

S. Gonnelli, A. Montagnani, C. Cepollaro, 2000, Osteoporosis International.

Quantitative ultrasound in the assessment of skeletal status in uremic patients.

N. Di Paolo, S. Gonnelli, A. Montagnani, 1999, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

Prevention of early postmenopausal bone loss using low doses of conjugated estrogens and the non-hormonal, bone-active drug ipriflavone

C. Gennari, L. Bufalino, D. Agnusdei, 2005, Osteoporosis International.

A new serum assay to measure N-terminal fragment of telopeptide of type I collagen in patients with renal osteodystrophy.

N. Di Paolo, S. Gonnelli, A. Montagnani, 2003, European journal of internal medicine.

Ipriflavone: New insights into its mechanisms of action on bone remodeling

E. Bonucci, M. Brandi, C. Gennari, 1993, Calcified Tissue International.

Ipriflavone and low doses of estrogens in the prevention of bone mineral loss in climacterium

A. Paoletti, C. Gennari, P. Fioretti, 1992 .

Short-term treatment of Paget's disease of bone with ipriflavone.

M. Passeri, S. Gonnelli, C. Gennari, 1992, Bone and mineral.

Effects of ipriflavone on bone mass and bone remodeling in patients with established postmenopausal osteoporosis

M. Passeri, A. Ventura, C. Gennari, 1992 .

Calcium-channel blockade (nitrendipine) in combination with ACE inhibition (captopril) in the treatment of mild to moderate hypertension

C. Gennari, R. Nami, G. Pavese, 1989, Cardiovascular Drugs and Therapy.

Reactive arthritis by Staphylococcus epidermidis: Report of an unusual case

S. Mondillo, C. Gennari, E. Battisti, 2005, Clinical Rheumatology.

Most Helicobacter pylori-Infected Patients Have Specific Antibodies, and Some Also Have H. pylori Antigens and Genomic Material in Bile: Is It a Risk Factor for Gallstone Formation?

C. Vindigni, C. Gennari, D. Vaira, 1998, Digestive Diseases and Sciences.

HLA antigens and primary osteoarthritis of the hand.

C. Gennari, L. Gennari, D. Merlotti, 2003, The Journal of rheumatology.

Activity of omeprazole on Helicobacter pylori and relation to toxicity of strains.

C. Gennari, J. Crabtree, M. Bugnoli, 1994, Journal of clinical pathology.

and relation to toxicity of strains . Activity of omeprazole on Helicobacter pylori

C. Gennari, J. Crabtree, M. Bugnoli, 2022 .

cagA positive and negative Helicobacter pyloristrains are simultaneously present in the stomach of most patients with non-ulcer dyspepsia: relevance to histological damage

C. Vindigni, D. Marrelli, A. Covacci, 1998, Gut.

Effects of a new glucocorticoid, oxazacort, on some variables connected with bone metabolism in man: a comparison with prednisone.

C. Gennari, M. Marchetti, F. B. Nicolis, 1977, International journal of clinical pharmacology and biopharmacy.

R. Civitelli, C. Gennari, L. Gennari, 1998, Calcified Tissue International.

The Role of Calcitriol in the Treatment of Osteoporosis

P. Sambrook, J. Gallagher, M. Passeri, 2000, Calcified Tissue International.

Risk Factors for Hip Fracture in Men from Southern Europe: The MEDOS Study

O. Johnell, J. Ranstam, J. Kanis, 1999, Osteoporosis International.

Risk factors for hip fracture in european women: The MEDOS study

O. Johnell, J. Kanis, J. Dequeker, 1995 .

Bone and renal responsiveness to parathyroid hormone with aging

C. Gennari, D. Agnusdei, 1994, Journal of Bone and Mineral Metabolism.

Calcitonin and estrogens

R. Civitelli, C. Gennari, D. Agnusdei, 1990, Journal of endocrinological investigation.

Calcitonin, estrogens and the bone

C. Gennari, D. Agnusdei, 1990, The Journal of Steroid Biochemistry and Molecular Biology.

Intestinal Absorption of Calcium-47 after Treatment with Oral Oestrogen-gestogens in Senile Osteoporosis

C. Gennari, L. Cesari, A. Caniggia, 1970, British medical journal.

Intestinal absorption of 45Ca in senile osteoporosis.

C. Gennari, A. Caniggia, R. Guideri, 2009, Acta medica Scandinavica.

Effect of chronic treatment with ipriflavone in postmenopausal women with low bone mass

S. Ortolani, U. Serni, S. Adami, 2009, Calcified Tissue International.

A Double Blind, Placebo-Controlled Trial of Ipriflavone for Prevention of Postmenopausal Spinal Bone Loss

S. Ortolani, M. Passeri, G. Crepaldi, 1997, Calcified Tissue International.

Effect of L-lysine on cytosolic calcium homeostasis in cultured human normal fibroblasts

L. Avioli, R. Civitelli, C. Gennari, 1989, Calcified Tissue International.

Acute changes in urinary radiocalcium following glucocorticoids administration in man.

L. Fusi, L. Avioli, B. Imbimbo, 1984, Advances in experimental medicine and biology.

Urinary cyclic adenosine monophosphate in young adults and elderly subjects.

C. Gennari, M. Galli, M. Montagnani, 1976, Journal of clinical pathology.

Intestinal absorption of phosphate in man: effect of drugs.

L. Fusi, C. Gennari, P. Nardi, 1986, Advances in experimental medicine and biology.

Dissociation of absorptions of calcium and phosphate in different pathophysiological states in man.

L. Fusi, C. Gennari, M. Bernini, 1984, Advances in experimental medicine and biology.

Seasonal variation in urinary excretion of cyclic AMP in healthy people

G. Francini, C. Gennari, M. Galli, 1981, Journal of endocrinological investigation.

Circulating Levels of Immunoreactive Peptides and Steroid Hormones in Bronchogenic Carcinoma

G. Francini, S. Gonnelli, B. Lucani, 1986, The International journal of biological markers.

Urinary excretion of cyclic adenosine 3',5'-monophosphate and cyclic guanosine 3',5'-monophosphate in malignancy.

G. Francini, C. Gennari, M. Galli, 1978, Journal of clinical pathology.

[Effects on the bones of nandrolone decanoate therapy in postmenopausal osteoporosis].

S. Gonnelli, C. Gennari, D. Agnusdei, 1989, Minerva endocrinologica.

Differential effect of glucocorticoids on calcium absorption and bone mass.

C. Gennari, 1993, British journal of rheumatology.

Dual X-ray Absorptiometry and Bone Ultrasonography in Patients with Rett Syndrome

S. Rossi, S. Gonnelli, S. Pacini, 2001, Calcified Tissue International.

Calcitonin treatment of osteoporosis in Italy

C. Gennari, G. Mazzuoli, 1992, The Lancet.

Migraine Prophylaxis with Salmon Calcitonin: a Cross‐over Double‐blind, Placebo‐controlled Study

S. Gonnelli, C. Gennari, C. Vibelli, 1986, Headache.

The variable incidence of hip fracture in Southern Europe: The MEDOS study

O. Johnell, J. Dequeker, M. Passeri, 1994, Osteoporosis International.

Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: four-year results from a randomized clinical trial.

J. Reginster, H. Genant, R. Eastell, 2002, The Journal of clinical endocrinology and metabolism.

Dietary L-lysine and calcium metabolism in humans.

L. Avioli, R. Civitelli, D. Villareal, 1992, Nutrition.

Effect of Electromagnetic Fields on Bone Mineral Density and Biochemical Markers of Bone Turnover in Osteoporosis: A Single-Blind, Randomized Pilot Study

Nicola Giordano, C. Gennari, L. Gennari, 2001 .

[Physiopathology and therapy of localized osteopenia].

C. Gennari, M. Montagnani, 1991, Minerva medica.

Influence of intravenous β-adrenergic blockade with or without partial agonist activity upon plasma cyclic AMP and catecholamines in healthy subjects

P. Verdecchia, G. Francini, C. Gennari, 2004, European Journal of Clinical Pharmacology.

Validation of a food frequency questionnaire for nutritional calcium intake assessment in Italian women

S. Gonnelli, C. Gennari, S. Rossi, 2002, European Journal of Clinical Nutrition.

Effects of prednisone and deflazacort on mineral metabolism and parathyroid hormone activity in humans

L. Avioli, B. Imbimbo, C. Gennari, 1984, Calcified Tissue International.

Prostaglandin PGE2: A possible mechanism for bone destruction in calcinosis circumscripta

S. Bombardieri, C. Gennari, A. Vattimo, 1978, Calcified Tissue Research.

Analgesic-antiinflammatory effect of a 100 Hz variable magnetic field in RA.

B. Lucani, C. Gennari, E. Battisti, 2000, Clinical and experimental rheumatology.

Graphic Trace Analysis of Ultrasound at the Phalanges May Differentiate Between Subjects with Primary Hyperparathyroidism and with Osteoporosis: A Pilot Study

S. Gonnelli, A. Montagnani, C. Cepollaro, 2002, Osteoporosis International.

The infection by Helicobacter pylori strains expressing CagA is highly prevalent in women with autoimmune thyroid disorders.

C. Gennari, D. Vaira, N. Figura, 1999, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

Osteogenesis Imperfecta: Bone Turnover, Bone Density, and Ultrasound Parameters

S. Gonnelli, A. Montagnani, C. Cepollaro, 1999, Calcified Tissue International.

Genetic markers of osteoarticular disorders: facts and hopes

J. Reginster, M. Cerinic, M. Brandi, 2001, Arthritis research.

Initial increase of plasma radioactive calcium after intravenous injection of calcitonin in man.

C. Gennari, A. Vattimo, A. Caniggia, 1972, Clinical science.

Weill-Marchesani Syndrome: Report of an Unusual Case

C. Gennari, E. Battisti, N. Giordano, 1997, Calcified Tissue International.

Longitudinal association between sex hormone levels, bone loss, and bone turnover in elderly men.

R. Nuti, S. Gonnelli, B. Lucani, 2003, The Journal of clinical endocrinology and metabolism.

Use of calcitonin in the treatment of bone pain associated with osteoporosis

C. Gennari, D. Agnusdei, A. Camporeale, 2007, Calcified Tissue International.

Interim Report and Recommendations of the World Health Organization Task-Force for Osteoporosis

Harry K. Genant, Paul D. Miller, Bess Dawson-Hughes, 1999, Osteoporosis International.

Long-term efficacy of risedronate: a 5-year placebo-controlled clinical experience.

C. Cooper, J. Reginster, D. Mellström, 2003, Bone.

A. Silman, O. Johnell, C. Cooper, 2004, Osteoporosis International.

Determinants of incident vertebral fracture in men and women: results from the European Prospective Osteoporosis Study (EPOS)

A. Silman, O. Johnell, C. Cooper, 2003, Osteoporosis International.

Incidence of Limb Fracture across Europe: Results from the European Prospective Osteoporosis Study (EPOS)

A. Silman, O. Johnell, C. Cooper, 2002, Osteoporosis International.

Comparative prospective, double-blind, multicenter study of the efficacy of tiludronate and etidronate in the treatment of Paget's disease of bone.

M. Dougados, J. Reginster, C. Roux, 1995, Arthritis and rheumatism.

Fortnightly Review: Paget's disease of bone: diagnosis and management

J. Reginster, D. Hosking, P. Meunier, 1996, BMJ.

Association of tibolone and fluoride displays a pronounced effect on bone mineral density in postmenopausal osteoporotic women.

C. Gennari, J. Reginster, D. Agnusdei, 1999, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Effects of parathroid hormone and calcitonin on plasma and nephrogenous cclic adenosine‐3.,5 ‐monophosphate in normal subjects and in pathological conditions

R. Nuti, C. Gennari, A. Caniggia, 1980 .

Letter: Diphosphonate therapy in deafness associated with Paget's disease.

C. Gennari, I. Sensini, 1975, British medical journal.

Paget bone disease and heredity: a case report.

R. Civitelli, C. Gennari, D. Agnusdei, 1988, Henry Ford Hospital medical journal.

IgG and IgM antiganglioside M1 antibodies in primary Sjogren's syndrome with and without peripheral neuropathy

R. Nuti, B. Lucani, C. Gennari, 2003, Clinical Rheumatology.

Sjogren's syndrome and Helicobacter pylori infection

C. Vindigni, C. Gennari, D. Burroni, 1994 .

Sjörgren's syndrome and Helicobacteur pylori infection

C. Vindigni, C. Gennari, D. Burroni, 1994 .

Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment.

L. Avioli, R. Civitelli, S. Gonnelli, 1988, The Journal of clinical investigation.

CagA-positive Helicobacter pylori infection may increase the risk of food allergy development.

P. Rottoli, C. Gennari, N. Figura, 1999, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

Hyperuricemia and gout in thyroid endocrine disorders.

C. Gennari, N. Giordano, A. Amendola, 2001, Clinical and experimental rheumatology.

[Therapy with bromocriptine and behavior of various hormones in psoriasis patients].

M. Fimiani, L. Andreassi, G. Francini, 1984, Bollettino della Societa italiana di biologia sperimentale.

Bone Mass and Bone Loss in Secondary Osteoporosis

R. Nuti, C. Gennari, G. Martini, 1998 .

Intestinal Absorption of 45Ca in Stone-forming Patients

C. Gennari, L. Cesari, A. Caniggia, 1965, British medical journal.

A polymorphic CYP19 TTTA repeat influences aromatase activity and estrogen levels in elderly men: effects on bone metabolism.

M. Brandi, S. Gonnelli, B. Lucani, 2004, The Journal of clinical endocrinology and metabolism.

Design for an ipriflavone multicenter European fracture study

C. Christiansen, J. Reginster, C. Roux, 2009, Calcified Tissue International.

Acute antihypertensive, diuretic and metabolic effects of etozolin and chlorthalidone.

B. Lucani, C. Gennari, R. Nami, 1991, Panminerva medica.

PHARMACODYNAMIC ACTIVITY OF SYNTHETIC SALMON CALCITONIN IN OSTEOPOROTIC PATIENTS: COMPARISON BETWEEN RECTAL AND INTRAMUSCULAR ADMINISTRATION Pilot Study

S. Gonnelli, M. Campagna, C. Gennari, 1993 .

Antiphospholipid antibodies in patients with retinal vascular occlusions.

C. Traversi, C. Gennari, E. Battisti, 1998, Acta ophthalmologica Scandinavica.

[The efficacy and safety of glucosamine sulfate in the treatment of gonarthritis].

S. Gonnelli, M. Campagna, C. Gennari, 1996, La Clinica terapeutica.

Ipriflavone in the treatment of postmenopausal osteoporosis: a randomized controlled trial.

C. Christiansen, J. Reginster, P. Alexandersen, 2001, JAMA.

The effects of raloxifene on incident vertebral fractures in postmenopausal women with osteoporosis : 4-year results from the MORE trial

J. Reginster, H. Genant, R. Eastell, 2000 .

Effect of Ipriflavone—a Synthetic Derivative of Natural Isoflavones—on Bone Mass Loss in the Early Years After Menopause

S. Ortolani, M. Passeri, C. Gennari, 1998, Menopause.

Efficacy and tolerability of paroxetine in patients with fibromyalgia syndrome: a single-blind study

C. Gennari, E. Battisti, N. Giordano, 1999 .

Food allergy and Helicobacter pylori infection.

P. Rottoli, C. Gennari, D. Vaira, 1999, Italian journal of gastroenterology and hepatology.

Ultrasonographic assessment of bone in normal Italian males and females.

S. Gonnelli, C. Cepollaro, C. Gennari, 1995, The British journal of radiology.

Assessing the Response to Treatment for Osteoporosis

R. Nuti, C. Gennari, G. Martini, 1998 .

Long-term effects of raloxifene on bone mineral density, bone turnover, and serum lipid levels in early postmenopausal women: three-year data from 2 double-blind, randomized, placebo-controlled trials.

C. Christiansen, P. Delmas, B. Mitlak, 2000, Archives of internal medicine.

Analgesic activity of salmon anf human calcitonin against cancer pain: a double-blind. placebo-controlled clinical study

R. Civitelli, S. Gonnelli, C. Gennari, 1985 .

Alendronate Treatment in Men With Primary Osteoporosis: A Three-Year Longitudinal Study

S. Gonnelli, A. Montagnani, C. Cepollaro, 2003, Calcified Tissue International.

HELICOBACTER PYLORI INFECTION AND PRIMARY SJOGREN'S SYNDROME: A POSSIBLE ASSOCIATION AND NEW THERAPEUTIC APPROACH

C. Gennari, N. Figura, E. Battisti, 1995 .

Sjögren's syndrome and pure red cell aplasia.

C. Gennari, E. Battisti, N. Giordano, 1996, Clinical and experimental rheumatology.

CALCITONINS AND OSTEOPOROSIS

C. Gennari, D. Agnusdei, 1994, The British journal of clinical practice.

Diagnostic value of ultrasound analysis and bone densitometry as predictors of vertebral deformity in postmenopausal women

S. Rossi, S. Gonnelli, C. Cepollaro, 2005, Osteoporosis International.

Effect on bone mass and bone turnover of a 2-year intermittent or continuous treatment with salmon calcitonin nasal spray in postmenopausal osteoporotic patients

C. Cepollaro, C. Gennari, D. Agnusdei, 1992 .

Biological activity of different calcitonins in men

R. Civitelli, S. Gonnelli, C. Gennari, 1990, Experimental Gerontology.

Clinical utility of bone mass measurements in adults: consensus of an international panel. The Society for Clinical Densitometry.

H K Genant, R R Recker, J Dequeker, 1996, Seminars in arthritis and rheumatism.

Effects of pravastatin treatment on vitamin D metabolites.

S. Gonnelli, A. Montagnani, C. Gennari, 1994, Clinical therapeutics.

Relevance of hydration state of the fat free mass in estimating fat mass by body impedance analysis.

C. Gennari, M. Montomoli, G. Guzzo, 1998, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

Sites and modes of action of an estrogen-gestagen combination on calcium and phosphate metabolism in postmenopausal osteoporosis.

C. Gennari, A. Caniggia, 1972, Clinical orthopaedics and related research.

Acute effects of salmon, human and porcine calcitonin on plasma calcium and cyclic AMP levels in man

G. Francini, S. Gonnelli, C. Gennari, 1981 .

Effect of Calcium Supplementation as a High-Calcium Mineral Water on Bone Loss in Early Postmenopausal Women

S. Gonnelli, C. Cepollaro, C. Gennari, 1996, Calcified Tissue International.

Thymostimulin in Association with Chemotherapy in Breast Cancer Patients with Bone Metastases

R. Petrioli, S. Gonnelli, C. Cepollaro, 1995 .

Hypertension and primary hyperparathyroidism: the role of adrenergic and renin-angiotensin-aldosterone systems.

S. Gonnelli, C. Gennari, R. Nami, 1995, Mineral and electrolyte metabolism.

The combined use of ultrasound and densitometry in the prediction of vertebral fracture.

S. Rossi, S. Gonnelli, A. Montagnani, 1997, The British journal of radiology.

Parathyroid hormone-related protein and arteriolar tone in hypertensives

B. Lucani, C. Gennari, L. Gennari, 1994, Journal of Bone and Mineral Metabolism.

Usefulness of bone quantitative ultrasound in management of osteoporosis in men.

S. Gonnelli, A. Montagnani, C. Cepollaro, 2001, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

Activity ofomeprazole onHelicobacter pyloni and relation totoxicity ofstrains

C. Gennari, M. Bugnoli, N. Figura, 2011 .

Falls explain between-center differences in the incidence of limb fracture across Europe.

A. Silman, O. Johnell, C. Cooper, 2002, Bone.

Human recombinant growth hormone with and without salmon calcitonin in the treatment of postmenopausal osteoporosis

S. Gonnelli, C. Cepollaro, M. Campagna, 1992 .

INTESTINAL ABSORPTION OF 45CA DYNAMICS OF 45CA IN GASTRECTOMY OSTEOPOROSIS.

C. Gennari, L. Cesari, A. Caniggia, 2009, Acta medica Scandinavica.

Ipriflavone in the Treatment of Postmenopausal Osteoporosis

C. Christiansen, J. Reginster, P. Alexandersen, 2017 .

Acute Hepatitis Induced by Cyproterone Acetate

C. Gennari, N. Giordano, P. Nardi, 2001, The Annals of pharmacotherapy.